Clinical Trial Update: Effects of LP-LDL® on Lipid Metabolism, Glycemic Control, Inflammatory Markers, and Cognitive Function in Individuals With Prediabetes and Diabetes Mellitus [NA]

View source ↗

Summary

This clinical trial update describes a study evaluating LP-LDL® effects on lipid metabolism, glycemic control, inflammatory markers, and cognitive function in i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prediabetes
• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• LP-LDL®

Snippet

Sponsor: Aalborg University | Conditions: Diabete Type 1, Diabete Type 2 | NA | Status: NOT_YET_RECRUITING